Seeking Alpha

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application...

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application for the generic version of Shire's (SHPG) Adderall XR capsules for the treatment of ADD. Adderall XR had annual sales, including brand and generic sales, of approximately $2B in the U.S. last year.
From other sites
Comments (5)
  • Michael Bryant
    , contributor
    Comments (5823) | Send Message
     
    (TEVA) is undervalued.
    14 Feb 2013, 03:36 PM Reply Like
  • chopchop0
    , contributor
    Comments (4008) | Send Message
     
    It's been "undervalued" for the last several quarters.
    14 Feb 2013, 04:14 PM Reply Like
  • Energysystems
    , contributor
    Comments (1590) | Send Message
     
    The only loser in my portfolio. Holding and DRIP'ing though, because I think the JV with PG will be a big winner in the long run.
    14 Feb 2013, 04:28 PM Reply Like
  • Michael Bryant
    , contributor
    Comments (5823) | Send Message
     
    I think main problem now is the climate surrounding Israel.
    14 Feb 2013, 06:11 PM Reply Like
  • Energysystems
    , contributor
    Comments (1590) | Send Message
     
    Plus they still have the upcoming Copaxone overhang, and that's a big bit of overall revenues. It's already put pressure on the stock price.
    14 Feb 2013, 06:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs